谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Dose Escalation of Blinatumomab Is a Better Option for MRD-Positive CR Patients, Results from a Single-Center Real World Study of Blinatumomab for B-Cell Acute Lymphoblastic Leukemia in China

Sijie Tang,Jiayi Ren,Weiyang Liu,Xiangqin Weng,Yongmei Zhu,Cheng Wang,Lijun Peng,Wenqian Xu, Yuxuan Shang,Wenyan Yu,Jiaojiao Zhang,Jie Xu,Yuanfang Liu,Weiping Zhang,Jian-Qing Mi,Jin Wang

BLOOD（2023）

引用 0|浏览32
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要